Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

BUY
$37.58 - $52.57 $4,922 - $6,886
131 Added 11.57%
1,263 $51,000
Q4 2022

Feb 03, 2023

SELL
$49.7 - $57.71 $38,567 - $44,782
-776 Reduced 40.67%
1,132 $57,000
Q3 2022

Nov 02, 2022

BUY
$53.86 - $66.8 $72,226 - $89,578
1,341 Added 236.51%
1,908 $103,000
Q2 2022

Jul 18, 2022

SELL
$63.83 - $80.0 $10,148 - $12,720
-159 Reduced 21.9%
567 $36,000
Q1 2022

Apr 19, 2022

SELL
$76.85 - $89.45 $4,303 - $5,009
-56 Reduced 7.16%
726 $56,000
Q4 2021

Jan 24, 2022

SELL
$74.57 - $87.19 $4,772 - $5,580
-64 Reduced 7.57%
782 $67,000
Q3 2021

Oct 19, 2021

BUY
$73.77 - $83.61 $19,917 - $22,574
270 Added 46.88%
846 $68,000
Q2 2021

Jul 13, 2021

BUY
$80.5 - $88.01 $3,381 - $3,696
42 Added 7.87%
576 $46,000
Q1 2021

May 03, 2021

SELL
$76.38 - $86.03 $5,346 - $6,022
-70 Reduced 11.59%
534 $45,000
Q4 2020

Feb 04, 2021

BUY
$75.39 - $82.36 $20,430 - $22,319
271 Added 81.38%
604 $48,000
Q3 2020

Oct 26, 2020

SELL
$78.33 - $90.73 $548 - $635
-7 Reduced 2.06%
333 $27,000
Q2 2020

Jul 06, 2020

SELL
$78.66 - $94.14 $4,404 - $5,271
-56 Reduced 14.14%
340 $29,000
Q1 2020

Apr 13, 2020

SELL
$71.57 - $93.3 $21,971 - $28,643
-307 Reduced 43.67%
396 $32,000
Q4 2019

Feb 05, 2020

BUY
$76.7 - $88.45 $20,018 - $23,085
261 Added 59.05%
703 $59,000
Q3 2019

Oct 08, 2019

BUY
$81.4 - $89.78 $1,383 - $1,526
17 Added 4.0%
442 $39,000
Q2 2019

Aug 20, 2019

BUY
$73.44 - $82.41 $6,609 - $7,416
90 Added 26.87%
425 $35,000
Q4 2018

Jan 25, 2019

BUY
$61.45 - $77.8 $20,585 - $26,063
335 New
335 $22,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.